H. Schwende

1.2k total citations
21 papers, 659 citations indexed

About

H. Schwende is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, H. Schwende has authored 21 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in H. Schwende's work include Heart Failure Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac pacing and defibrillation studies (4 papers). H. Schwende is often cited by papers focused on Heart Failure Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac pacing and defibrillation studies (4 papers). H. Schwende collaborates with scholars based in Germany, Switzerland and United Kingdom. H. Schwende's co-authors include Peter Dieter, Edith Fitzke, Petra Ambs, Hisashi Hidaka, Justus Duyster, Ralf Hoffmann, Christian Mueller, Domingo A. Pascual‐Figal, Rolf Wachter and Cândida Fonseca and has published in prestigious journals such as The Journal of Immunology, Biochemical Journal and European Heart Journal.

In The Last Decade

H. Schwende

21 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Schwende Germany	7	245	235	76	63	63	21	659
Patricia R. Souza United Kingdom	16	279 1.1×	351 1.5×	33 0.4×	40 0.6×	94 1.5×	17	883
Thiago A. Patente Brazil	13	369 1.5×	270 1.1×	28 0.4×	126 2.0×	73 1.2×	26	754
James L. Catalfamo United States	19	110 0.4×	308 1.3×	66 0.9×	59 0.9×	49 0.8×	58	1.2k
Zahra Ahmadi Iran	15	217 0.9×	146 0.6×	37 0.5×	141 2.2×	74 1.2×	33	669
Shauna Dauphinee Canada	11	374 1.5×	353 1.5×	24 0.3×	63 1.0×	83 1.3×	18	813
Anna Monica Bianco Italy	16	148 0.6×	337 1.4×	132 1.7×	35 0.6×	80 1.3×	45	819
Tianshu Yang China	17	170 0.7×	447 1.9×	49 0.6×	82 1.3×	81 1.3×	38	939
Simone Marcone Ireland	16	82 0.3×	443 1.9×	66 0.9×	98 1.6×	54 0.9×	26	728
Gernot Kriegshäuser Austria	17	316 1.3×	358 1.5×	40 0.5×	213 3.4×	62 1.0×	53	1.1k
Marianna M. Koga Brazil	11	204 0.8×	245 1.0×	18 0.2×	38 0.6×	59 0.9×	15	526

Countries citing papers authored by H. Schwende

Since Specialization

Citations

This map shows the geographic impact of H. Schwende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Schwende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Schwende more than expected).

Fields of papers citing papers by H. Schwende

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Schwende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Schwende. The network helps show where H. Schwende may publish in the future.

Co-authorship network of co-authors of H. Schwende

This figure shows the co-authorship network connecting the top 25 collaborators of H. Schwende. A scholar is included among the top collaborators of H. Schwende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Schwende. H. Schwende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhatt, Ankeet S., et al.. (2025). Real-World Comparative Effectiveness of Sacubitril/Valsartan Versus RAS Inhibition Alone in Patients with De Novo Heart Failure. ESC Heart Failure. 12(3). 1682–1692. 1 indexed citations

Straburzyńska‐Migaj, Ewa, Michele Senni, Rolf Wachter, et al.. (2023). Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study. Journal of Cardiac Failure. 30(3). 425–435. 4 indexed citations

Witte, Klaus K., Rolf Wachter, Michele Senni, et al.. (2022). Influence of Diabetes on Sacubitril/Valsartan Titration and Clinical Outcomes in Patients Hospitalized for Heart Failure. ESC Heart Failure. 10(1). 80–89. 6 indexed citations

Chandra, Alvin, Carísi Anne Polanczyk, Brian Claggett, et al.. (2022). Health‐related quality of life outcomes in PARAGON‐HF. European Journal of Heart Failure. 24(12). 2264–2274. 9 indexed citations

Senni, Michele, Rolf Wachter, Klaus K. Witte, et al.. (2019). Initiation of Sacubitril/Valsartan Shortly After Hospitalisation for Acutely Decompensated Heart Failure in Patients with Newly Diagnosed ( de novo ) Heart Failure: A Subgroup Analysis of the TRANSITION Study. European Journal of Heart Failure. 22(2). 303–312. 43 indexed citations

Wachter, Rolf, Michele Samaja, Ewa Straburzyńska‐Migaj, et al.. (2019). Initiation of Sacubitril/Valsartan in Patients with De Novo Heart Failure with Reduced Ejection Fraction: An Analysis of the Transition Study. Heart Lung and Circulation. 28. S178–S178. 2 indexed citations

Wachter, Rolf, Michele Samaja, Ewa Straburzyńska‐Migaj, et al.. (2019). In-Hospital Initiation of Sacubitril/Valsartan in Stabilised Patients with Heart Failure and Reduced Ejection Fraction Naïve to Renin-Angiotensin System Blocker: An Analysis of the Transition Study. Heart Lung and Circulation. 28. S177–S178. 2 indexed citations

Pascual‐Figal, Domingo A., W. Bao, Michele Senni, et al.. (2019). 1410Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study. European Heart Journal. 40(Supplement_1). 1 indexed citations

Senni, Michele, Rolf Wachter, Jan Bělohlávek, et al.. (2018). P6531Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF. European Heart Journal. 39(suppl_1). 2 indexed citations

10.

Kaplan, Alan, et al.. (2016). Comparison of Angioedema in Heart Failure Patients Treated with Sacubitril/Valsartan or Enalapril in the PARADIGM-HF Study. Journal of Cardiac Failure. 22(8). S66–S67. 3 indexed citations

11.

Junge, G., Thomas Dumortier, H. Schwende, & John J. Fung. (2013). mTOR Inhibition in Liver Transplantation: How to Dose for Effective/Safe CNI Reduction?. Transplantation Proceedings. 45(5). 1979–1980. 2 indexed citations

12.

Dengler, T.J., H. Schwende, Stefan Scheidl, et al.. (2010). Incidences of incisional complications after de novo cardiac transplantation in AZA-, MMF- or everolimus-based regimens: a cross-study analysis on 1008 patients. The Thoracic and Cardiovascular Surgeon. 58(S 01). 1 indexed citations

13.

Chan, Laurence, Hany Riad, Gunnar Tufveson, et al.. (2010). BETTER RENAL ALLOGRAFT FUNCTION WITH EVEROLIMUS FACILITATED CNI REDUCTION - GRAFT TYPE, DONOR CRITERIA AND GENDER ANALYSIS. Transplantation. 90. 296–296. 1 indexed citations

14.

Dieter, Peter & H. Schwende. (2000). Protein kinase C-α and -β play antagonistic roles in the differentiation process of THP-1 cells. Cellular Signalling. 12(5). 297–302. 24 indexed citations

15.

Ambs, Petra, Manuela Baccarini, H. Schwende, Edith Fitzke, & Peter Dieter. (1997). Regulation of Cytosolic Phospholipase A2 in Arachidonic Acid Release of Rat-Liver Macrophages. Advances in experimental medicine and biology. 407. 479–483. 2 indexed citations

16.

Schwende, H., Edith Fitzke, Petra Ambs, & Peter Dieter. (1997). Formation of Eicosanoids during Differentiation of Thp-1 Cells. Advances in experimental medicine and biology. 407. 491–495. 3 indexed citations

17.

Dieter, Peter, Petra Ambs, Edith Fitzke, & H. Schwende. (1997). Lipopolysaccharide and Liposome-Encapsulated MTP-PE- Induced Cytotoxicity and Release of Eicosanoids, Tumor Necrosis Factor- α and Nitric Oxide in Liver Macrophages. Advances in experimental medicine and biology. 407. 485–490. 5 indexed citations

18.

Schwende, H., Edith Fitzke, Petra Ambs, & Peter Dieter. (1996). Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. Journal of Leukocyte Biology. 59(4). 555–561. 487 indexed citations

19.

Dieter, Peter, Petra Ambs, Edith Fitzke, et al.. (1995). Comparative studies of cytotoxicity and the release of TNF-α, nitric oxide, and eicosanoids of liver macrophages treated with lipopolysaccharide and liposome-encapsulated MTP-PE. The Journal of Immunology. 155(5). 2595–2604. 28 indexed citations

20.

Duyster, Justus, H. Schwende, Edith Fitzke, Hisashi Hidaka, & Peter Dieter. (1993). Different roles of protein kinase C-β and -δ in arachidonic acid cascade, superoxide formation and phosphoinositide hydrolysis. Biochemical Journal. 292(1). 203–207. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact